AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Lexaria Bioscience Corp. Director's Dealing 2025

May 16, 2025

34983_dirs_2025-05-16_16ad2483-e9dd-401d-b92e-787ec01c0c8a.zip

Director's Dealing

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Lexaria Bioscience Corp. (LEXX)
CIK: 0001348362
Period of Report: 2025-05-15

Reporting Person: Baxter Nicholas W (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-05-15	Stock Options	$1.04	A	11000	Acquired	2030-05-15	Common Shares (11000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
common shares	11000	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Options	$3	2026-04-26	Common Shares (1500)	1500	Direct
Stock Options	$3	2026-06-08	Common Shares (5000)	6500	Direct
Stock Options	$3	2026-09-01	Common Shares (1900)	8400	Direct
Stock Options	$3.39	2027-03-08	Common Shares (3400)	11800	Direct
Stock Options	$1.96	2027-10-12	Common Shares (18200)	30000	Direct
Stock Options	$0.87	2028-07-25	Common Shares (5000)	35000	Direct
Stock Options	$2.36	2029-04-26	Common Shares (5000)	40000	Direct
Stock Options	$3.39	2029-07-26	Common Shares (12000)	52000	Direct